Dual Pharmacological Inhibition of Angiopoietin-2 and VEGF-A in Murine Experimental Sepsis
Authors:
- 14 November 2019
- journal article
- research article
- Published by S. Karger AG in Journal of Vascular Research
- Vol. 57 (1) , 34-45
Abstract
Background: Sepsis is a pathological host response to infection leading to vascular barrier breakdown due to elevated levels of angiopoietin-2 (Angpt-2) and vascular endothelial growth factor-A (VEGF-A). Here, we tested a novel heterodimeric bispecific monoclonal IgG1-cross antibody of Angpt-2 and VEGF – termed “A2V.” Methods: Cecal ligation and puncture was used to induce murine polymicrobial sepsis. Organs and blood were harvested for fluorescence immunohistochemistry and RT-PCR, and survival was recorded. In vitro endothelial cells were stimulated with plasma from septic shock patients costimulated with A2V or IgG antibody followed by immunocytochemistry and real-time transendothelial electrical resistance. Results: Septic mice treated with A2V had a reduced induction of the endothelial adhesion molecule ICAM-1, leading to a trend towards less transmigration of inflammatory cells (A2V: 42.2 ± 1.0 vs. IgG 48.5 ± 1.7 Gr-1+ cells/HPF, p = 0.08) and reduced tissue levels of inflammatory cytokines (e.g., IL-6 mRNA: A2V 9.4 ± 3.2 vs. IgG 83.9 ± 36.7-fold over control, p = 0.03). Endothelial permeability was improved in vivo and in vitro in stimulated endothelial cells with septic plasma. Survival was improved by 38% (p = 0.02). Conclusion: Dual inhibition of Angpt-2 and VEGF-A improves murine sepsis morbidity and mortality, making it a potential therapeutic against vascular barrier breakdown.Keywords
This publication has 32 references indexed in Scilit:
- Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsisJournal of Clinical Investigation, 2013
- Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsisCritical Care, 2013
- Angiopoietin-1 variant reduces LPS-induced microvascular dysfunction in a murine model of sepsisCritical Care, 2012
- The synthetic Tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsisCritical Care, 2011
- Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodiesProceedings of the National Academy of Sciences, 2011
- Effects of a synthetic PEG-ylated Tie-2 agonist peptide on endotoxemic lung injury and mortalityAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- COMP-Angiopoietin-1 decreases lipopolysaccharide-induced acute kidney injuryKidney International, 2009
- COMP-Ang1 ameliorates leukocyte adhesion and reinforces endothelial tight junctions during endotoxemiaBiochemical and Biophysical Research Communications, 2009
- Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortalityJournal of Experimental Medicine, 2006
- Excess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in HumansPLOS Medicine, 2006